Skip Ribbon Commands
Skip to main content
Home Administrative Billing & Reimbursement BlueCard® Health and Wellness Medical PEAR portal Pharmacy Products Quality Management

​​Changes to medical policy on percutaneous coronary intervention, coronary angiography, and arterial ultrasound​

November 23, 2022

​Effective for dates of service on or after November 6, 2022, AIM Specialty Health® (AIM) has revised their Advanced Imaging Clinical Appropriateness Guidelines for Diagnostic Coronary Angiography for Independence Blue Cross (Independence) and Independence Administrators Commercial and Medicare Advantage members. For full details, view the specific guidelines.

For more information on AIM's revised Advanced Imaging Clinical Appropriateness Guidelines for Diagnostic Coronary Angiography, please refer to the following Independence policies on our Medical and Claim Payment Policy Portal, which will be published on December 5, 2022:

  • Commercial: #11.02.27f: Percutaneous Coronary Intervention, Coronary Angiography and Arterial Ultrasound
  • Medicare Advantage: #MA11.113f: Percutaneous Coronary Intervention, Coronary Angiography and Arterial Ultrasound

This content was prepared for the Provider News Center and may not be reproduced in any way without the express written permission of Independence Blue Cross. Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association.
Connect with us     Facebook     Twitter     Flickr     YouTube     Walk the Talk    Independence Pinterest    Independence LinkedIn    Independence Instagram Site Map        Anti-Fraud        Privacy Policy        Legal        Disclaimer
© 2023 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.